This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


2i07

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:2i07.jpg|left|200px]]
+
{{Seed}}
 +
[[Image:2i07.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2i07| PDB=2i07 | SCENE= }}
{{STRUCTURE_2i07| PDB=2i07 | SCENE= }}
-
'''Human Complement Component C3b'''
+
===Human Complement Component C3b===
-
==Overview==
+
<!--
-
Resistance to infection and clearance of cell debris in mammals depend on the activation of the complement system, which is an important component of innate and adaptive immunity. Central to the complement system is the activated form of C3, called C3b, which attaches covalently to target surfaces to amplify complement response, label cells for phagocytosis and stimulate the adaptive immune response. C3b consists of 1,560 amino-acid residues and has 12 domains. It binds various proteins and receptors to effect its functions. However, it is not known how C3 changes its conformation into C3b and thereby exposes its many binding sites. Here we present the crystal structure at 4-A resolution of the activated complement protein C3b and describe the conformational rearrangements of the 12 domains that take place upon proteolytic activation. In the activated form the thioester is fully exposed for covalent attachment to target surfaces and is more than 85 A away from the buried site in native C3 (ref. 5). Marked domain rearrangements in the alpha-chain present an altered molecular surface, exposing hidden and cryptic sites that are consistent with known putative binding sites of factor B and several complement regulators. The structural data indicate that the large conformational changes in the proteolytic activation and regulation of C3 take place mainly in the first conversion step, from C3 to C3b. These insights are important for the development of strategies to treat immune disorders that involve complement-mediated inflammation.
+
The line below this paragraph, {{ABSTRACT_PUBMED_17051160}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 17051160 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_17051160}}
==About this Structure==
==About this Structure==
Line 28: Line 32:
[[Category: McCarthy, A.]]
[[Category: McCarthy, A.]]
[[Category: C3b consists of 12 domain]]
[[Category: C3b consists of 12 domain]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 06:55:12 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 08:35:38 2008''

Revision as of 05:35, 28 July 2008

Image:2i07.png

Template:STRUCTURE 2i07

Human Complement Component C3b

Template:ABSTRACT PUBMED 17051160

About this Structure

2I07 is a Protein complex structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Structure of C3b reveals conformational changes that underlie complement activity., Janssen BJ, Christodoulidou A, McCarthy A, Lambris JD, Gros P, Nature. 2006 Nov 9;444(7116):213-6. Epub 2006 Oct 15. PMID:17051160

Page seeded by OCA on Mon Jul 28 08:35:38 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/2i07"
Personal tools